Evidence map›Paper›PMID 30721931›Full record

ArticleThe American journal of clinical nutrition2019

A report of activities related to the Dietary Reference Intakes from the Joint Canada-US Dietary Reference Intakes Working Group.

Amanda J MacFarlane, Mary E Cogswell, Janet M de Jesus, Linda S Greene-Finestone, David M Klurfeld, Christopher J Lynch, Karen Regan, Sedigheh Yamini, Joint Canada-US Dietary Reference Intakes Working Group

Abstract read
In one paragraph

Article in The American journal of clinical nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amanda J MacFarlaneNutrition Research Division, Health Canada, Ottawa, ON, Canada.
Mary E CogswellNational Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA.
Janet M de JesusOffice of Disease Prevention and Health Promotion, US Department of Health and Human Services, Rockville, MD.
Linda S Greene-FinestoneCentre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, ON, Canada.
David M KlurfeldAgricultural Research Service, USDA, Beltsville, MD.
Christopher J LynchOffice of Nutrition Research, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
Karen ReganOffice of Nutrition Research, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
Sedigheh YaminiOffice of Nutrition and Food Labeling, Center for Food Safety and Applied Nutrition, US Food and Drug Administration, College Park, MD.
Joint Canada-US Dietary Reference Intakes Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The governments of the United States and Canada have jointly undertaken the development of the Dietary Reference Intakes (DRIs) since the mid-1990s. The Federal DRI committees from each country work collaboratively to identify DRI needs, prioritize nutrient reviews, advance work to resolve methodological issues that is necessary for new reviews, and sponsor DRI-related committees through the National Academies of Sciences, Engineering and Medicine. In recent years, the Joint Canada-US DRI Working Group, consisting of members from both Federal DRI committees, developed an open and transparent nomination process for prioritizing nutrients for DRI review, by which sodium, the omega-3 (n-3) fatty acids, vitamin E, and magnesium were identified. In addition, discussions during the nutrient nomination process prompted the Federal DRI committees to address previously identified issues related to the use of chronic disease endpoints when setting DRIs. The development of guiding principles for setting DRIs based on chronic disease risk reduction will be applied for the first time during the DRI review of sodium and potassium. In summary, the US and Canadian governments have worked collaboratively to adapt our approach to prioritizing nutrients for DRI review and to broaden the scope of the DRIs to better incorporate the concept of chronic disease risk reduction in order to improve public health.

Indexed as

Chronic DiseaseDietRecommended Dietary AllowancesResearchBiomedical ResearchCanadaFatty Acids, Omega-3GovernmentHumansMagnesiumNutrientsPotassiumSodiumUnited StatesVitamin EFatty Acids, Omega-3MagnesiumNutrientsPotassiumSodiumVitamin E

Identifiers

PMID30721931
PMCPMC6500900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.